Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R Bellon

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Breast Cancer Research and Treatment|November 4, 2016
Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapyLior Z Braunstein, Alphonse G Taghian, Andrzej Niemierko, et al.
The Breast Journal|January 7, 2015
Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtypeLior Z Braunstein, Andrzej Niemierko, Mina N Shenouda, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
The association between biological subtype and isolated regional nodal failure after breast-conserving therapyJennifer Y Wo, Alphonse G Taghian, Paul L Nguyen, et al.
The Breast Journal|August 27, 2019
Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experienceFaina Nakhlis, Meredith M Regan, Yoon S Chun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapyNils D Arvold, Alphonse G Taghian, Andrzej Niemierko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2008
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapyPaul L Nguyen, Alphonse G Taghian, Matthew S Katz, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 15, 2013
What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approachEren D Yeh, Heather A Jacene, Jennifer R Bellon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter StudyReshma Jagsi, Kent A Griffith, Jennifer R Bellon, et al.
Breast Cancer Research and Treatment|July 10, 2013
Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapyAndrea L Russo, Nils D Arvold, Andrzej Niemierko, et al.
The Breast Journal|September 13, 2011
ACR appropriateness criteria® locally advanced breast cancerShannon M Macdonald, Eleanor E R Harris, Douglas W Arthur, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Breast Cancer Research and Treatment|November 4, 2016
Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapyLior Z Braunstein, Alphonse G Taghian, Andrzej Niemierko, et al.
The Breast Journal|January 7, 2015
Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtypeLior Z Braunstein, Andrzej Niemierko, Mina N Shenouda, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
The association between biological subtype and isolated regional nodal failure after breast-conserving therapyJennifer Y Wo, Alphonse G Taghian, Paul L Nguyen, et al.
The Breast Journal|August 27, 2019
Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experienceFaina Nakhlis, Meredith M Regan, Yoon S Chun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapyNils D Arvold, Alphonse G Taghian, Andrzej Niemierko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2008
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapyPaul L Nguyen, Alphonse G Taghian, Matthew S Katz, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 15, 2013
What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approachEren D Yeh, Heather A Jacene, Jennifer R Bellon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter StudyReshma Jagsi, Kent A Griffith, Jennifer R Bellon, et al.
Breast Cancer Research and Treatment|July 10, 2013
Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapyAndrea L Russo, Nils D Arvold, Andrzej Niemierko, et al.
The Breast Journal|September 13, 2011
ACR appropriateness criteria® locally advanced breast cancerShannon M Macdonald, Eleanor E R Harris, Douglas W Arthur, et al.
Pageof 14